David Altarac, M.D.
Chief Medical Officer, IST
Dr. Altarac is an infectious diseases physician and pharmaceutical executive with more than 20 years’ experience leading clinical and regulatory functions. He previously served as the Chief Medical Officer of Entasis Therapeutics and held leadership positions at Shire Pharmaceuticals, NeoStem, Inc., and Merck & Co. in therapeutic areas including infectious diseases, oncology, ophthalmology, inflammation, and rare diseases. Dr. Altarac holds an M.D. degree from New York Medical College, a Master of Public Administration (M.P.A.) degree from New York University, and a B.A. in Chemistry from the State University of New York at Binghamton, NY.